Ruling Against Johnson & Johnson Unit Affirmed

Law360, New York (June 16, 2006, 12:00 AM EDT) -- In the latest development in a long-running battle over the multi-billion dollar market for drug-coated coronary stents, a federal judge in Delaware has affirmed a jury’s decision that a stent made by Cordis Corp. infringes on a patent held by Boston Scientific Corp.

Cordis—a subsidiary of Johnson & Johnson—will appeal U.S. District Judge Sue Robinson’s ruling.

In an order dated June 15, Judge Robinson struck down a motion on behalf of Cordis Corp. that sought judgment as a matter of law or a new trial on...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.